Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

PARIS--(BUSINESS WIRE)--Regulatory News: Pernod Ricard (Paris:RI): En application des articles 221-1 et 223-16 du Règlement Général de l'AMF, les émetteurs publient par communiqué et sur leur site Internet, le nombre total de droits de vote et le nombre d'actions composant le capital de la société s'ils ont varié par rapport à ceux publiés antérieurement : Situation au 31.05.2026 1) Nombre total d'actions en circulation composant le capital de la société 252 269 195     2) Nombre total de droit...

LONDON--(BUSINESS WIRE)--  05-June-2026 Issue: Mitsubishi HC Capital UK Plc Series 938 XS3092412660 Care Amendment Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 09-March-2026 Date To: 09-June-2026 Record Date: 08-June-2026 Value Date: 09-June-2026 Benchmark Rate: 3.64127% Margin: 0.57% Total Rate: 4.21127% Floor: 0% Number of Days: 92 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount D...

PARIS--(BUSINESS WIRE)--Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen jou...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital (Paris:TKO): https://www.tikehaucapital.com/fr/shareholders/regulatory-information Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price per day Market (MIC Code) TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 29/05/2026 FR0013230612 5 37...

LONDON--(BUSINESS WIRE)--  05-June-2026 Issue: Mitsubishi HC Capital UK Plc Series 928 XS2952012743 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 05-June-2026 Date To: 07-September-2026 Record Date: 02-September-2026 Value Date: 07-September-2026 Benchmark Rate: 6.992% Margin: 0.62% Total Rate: 7.612% Number of Days: 94 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Total Amount Due: ZAR...

LONDON--(BUSINESS WIRE)--  05-June-2026 Issue: Mitsubishi HC Capital UK Plc Series 936 XS3024893789 Care Amendment Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 09-March-2026 Date To: 09-June-2026 Record Date: 08-June-2026 Value Date: 09-June-2026 Benchmark Rate: 3.64127% Margin: 0.76% Total Rate: 4.40127% Floor: 0% Number of Days: 92 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount D...

TORONTO, Ontario--(BUSINESS WIRE)--Interpath Global is expanding its investment in veterinary education and industry engagement following the successful launch and continued growth of 4CYTE™ Epiitalis® Forte Dog. Originally developed to support joint health through Interpath’s patented plant seed oil Epiitalis®, the 4CYTE™ range has become one of Canada’s most recognised joint health brands, trusted by veterinarians, clinics, and pet owners alike. While the brand has experienced strong organic...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharg...